The FP7 European Multi-ITN (Marie Curie Action Initial Training Network) Project “Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies (FP7 ITN ARGENT)” was running from March 2014 to February 2018.

The main objective of this intersectorial and multidisciplinary ITN is to create a new generation of researchers and experts able to create the platform on which next-generation cancer therapy will be built. The consortium aims to train a cohort of 13 PhDs (Early Stage Researchers – ESRs) to subsequently act as leaders and ambassadors in the field. The ITN ARGENT strategy relies i) on improving our understanding of the processes and mechanisms underlying radiation damage on a nanoscopic level, ii) on the application of the improved know-how in the production and development of functionalised radiosensitzers, and iii) on the developments of concepts and codes for clinical applications taking into account the new information.

The research leading to these results has received funding from the European Union Seventh Framework Programme FP7-2013-ITN-ARGENT project, under grant agreement n°608163.